TP53 and carcinoma of esophagus: TP53–/– HGOs appear to be on a trajectory similar to TP53-deficient Barrett’s oesophagus, for which the presumed cell of origin is gastric cardia17, and proposed biomarkers of progression to oesophageal cancer include CNA acquisition and SV burden16,52.